if you bothered to read the announcements and quarterly reports and listen to the webinars you could've figured it out yourself.
As has been mentioned at least 100 times, the Doherty Institute - not Prescient - is running the COVID trial.
And secondly, is your investment in PTX seriously based on the outcomes of a pre-clinical trial in COVID? Particularly when there's others - including on the ASX - that are now well and truly into their Phase 2 and 3s (not to mention of course the vaccines).
PTX Price at posting:
6.8¢ Sentiment: Hold Disclosure: Held
